WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke NOAELPLANTIN wurde als Wortmarke am 16.06.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1542224 |
| Länder | 
|
| Basismarke |
Nr. 4020200100907,
15. Juni 2020
|
| Anmeldedatum | 16. Juni 2020 |
| Ablaufdatum | 23. September 2021 |
Markeninhaber
B-455, 52, Ewhayeodae-gil,
Seodaemun-gu
KR
Seodaemun-gu
KR
Markenvertreter
602, 23-6, Baumoe-ro 37-gil Seocho-gu
Seoul 06744
KR
Waren und Dienstleistungen
05
Pharmaceutical preparations; pharmaceutical agents affecting
sensory organs; thyroid and para-thyroid hormone
preparations; tonics [medicines]; oral contraceptive pills;
antiemetics; local anesthetics; bronchodilating
preparations; anti-cough drops; androgen preparations;
pituitary hormone preparations; pharmaceutical preparations
for treating diabetes; pharmaceutical agents affecting
metabolism; vaccines against flu; chilblain preparations;
pharmaceutical preparations for headache; anaesthetics;
pharmaceutical agents affecting peripheral nervous system;
pharmaceutical preparations for immunity adjustment;
nutritive substances for microorganisms; pharmaceutical for
the treatment of erectile dysfunction; pharmaceutical
preparations for urogenital organs; vitamin preparations;
pharmaceutical products for the treatment of bone diseases;
anti-inflammatory and antipyretic preparations;
pharmaceutical agents affecting digestive organs;
cardiovascular pharmaceutical preparations; nervines;
ophthalmic preparations; allergy medications;
chemico-pharmaceutical preparations; medicines for the
treatment of gastrointestinal diseases; injectable mineral
solutions for medical purposes; antioxidants for medical
purposes; haematogen; pharmaceutical preparations for tumor
treatment; multivitamin preparations; suppositories;
pharmaceutical preparations acting on the central nervous
system; pharmaceutical preparations for diagnosis;
sedatives; analgesics; vaginal washes for medical purposes;
pharmaceutical preparations for treating asthma; medicines
for dental purposes; haemorrhoid preparations;
pharmaceutical preparations for inhalation for the treatment
of pulmonary hypertension; vaccines against pneumococcal
infections; dermatological pharmaceutical products;
contraceptive preparations; antihypertensives; anti-uric
preparations; anti-diabetic pharmaceuticals; pharmaceutical
preparations for anus; antibiotic preparations; antibiotics;
anti-cancer preparations; anti-cancer treatment supplements;
antidepressants; anticoagulants; antineoplastics;
anti-dermoinfectives; antidotes; antipyretic analgesics;
febrifuges; vasoconstrictors; hypoglycemic agents; blood
thinners; pharmaceutical preparations for respiratory
organs; respiratory stimulants; inhaled pharmaceutical
preparations for the treatment of respiratory diseases and
disorders; pharmaceutical products for treating respiratory
diseases and asthma; mixed vitamin preparations;
preparations for the treatment of burns; disinfectants for
chemical toilets; chemotherapeutics; preparations for
treatment of hepatitis; preparations for treating colds;
preparations for the treatment of hyperlipidemia;
preparations for the treatment of hypercholesteremia;
pharmaceutical preparations for treating hypertension;
pharmaceutical preparations for the treatment of
osteoporosis; preparations for the treatment of
osteoporosis; injectable pharmaceuticals for treatment of
anaphylactic reactions; pharmaceutical preparations for
treating halitosis; nausea treatment preparations;
antiulcerants; pharmaceutical preparations for the treatment
of musculoskeletal disorders; preparations for the treatment
of muscle fatigue; pharmaceutical preparations for treating
chloasma; pharmaceutical preparations for the treatment of
diseases of the endocrine system; pharmaceutical
preparations for the treatment of eye diseases and
conditions; pharmaceutical preparations for treating
metabolic disorders; pharmaceutical preparations for
treating peripheral nervous system disorders; pharmaceutical
preparations for the treatment of dandruff; pharmaceutical
preparations for the treatment of rhinitis; radioactive
pharmaceutical preparations for in vivo diagnostics or
therapeutic use; pharmaceutical preparations for the
treatment of cells; medicines for treating intestinal
disorders; cardiovascular treatment preparations;
pharmaceutical preparations for the treatment of kidney
diseases; pharmaceutical preparations for the treatment of
disorders of the metabolic system; pharmaceutical
preparations for treating allergies; pharmaceutical
preparations and compositions for the treatment and
prevention of cancer; biopharmaceuticals for the treatment
of cancer; pharmaceutical products for the treatment of
cancer; pharmaceutical preparations for the treatment of
inflammatory disorders; pharmaceutical preparations and
substances for the treatment of gastro-intestinal diseases;
medicated mouth treatment preparations; transdermal patches
for medical treatment; pharmaceutical preparations for the
treatment of auto-immune diseases; pharmaceutical
preparations for the treatment of infectious diseases;
pharmaceutical preparations for the treatment of gout; drug
delivery agents; drug delivery agents consisting of
compounds that facilitate delivery of a wide range of
pharmaceuticals; drug delivery agents in the form of powders
that provide controlled release of the active ingredients
for a wide variety of pharmaceuticals; drug delivery agents
in the form of tablets that provide controlled release of
the active ingredients for a wide variety of
pharmaceuticals; drug delivery agents in the form of
capsules that provide controlled release of the active
ingredients for a wide variety of pharmaceuticals; drug
delivery agents that facilitate the delivery of
pharmaceutical preparations; drug delivery agents in the
form of dissolvable films that facilitate the delivery of
pharmaceutical preparations; delivery agents in the form of
dissolvable films that facilitate the delivery of
nutritional supplements; drug delivery agents in the form of
coatings for tablets that facilitate the delivery of
pharmaceutical preparations; delivery agents in the form of
coatings for tablets that facilitate the delivery of
nutritional supplements
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 07. Februar 2022 | 2022/9 Gaz | KR | RAW: Total Ceasing Effect |
| 28. Oktober 2021 | 2021/44 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 29. Juli 2021 | 2021/30 Gaz | JP | Ablehnung |
| 15. Februar 2021 | 2021/7 Gaz | IN | Ablehnung |
| 26. Januar 2021 | 2021/4 Gaz | AU | Ablehnung |
| 10. Dezember 2020 | 2020/51 Gaz | EM | Ablehnung |
| 12. November 2020 | 2020/47 Gaz | RU | Ablehnung |
| 05. November 2020 | 2020/45 Gaz | CN | Ablehnung |
| 21. Oktober 2020 | 2020/43 Gaz | US | Ablehnung |
| 16. Juni 2020 | 2020/28 Gaz | KR | Eintragung |
ID: 141542224